ANNOUNCEMENTS

Congratulations to the Chicago Blackhawks for winning the 2013 Stanley Cup.

Congratulations to Conn Smythe Trophy winner Patrick Kane.


UPDATES


- The NHL Players Overseas for Lockout list is current as of 2:35 PM January 6, 2013.

- The 2012 Free Agents list and 2012 Free Agent Signings list are current as of 2:35 PM January 6, 2013.

- The 2011 Free Agents list and 2011 Free Agent Signings list are current as of 1:09 PM June 16, 2012.

- The Atlanta Thrashers have been re-designated Winnipeg on the 2011 Free Agents list. Any signings that were completed prior to May 31, 2011 will be listed as "Atlanta/Winnipeg." Any signings completed after May 31, 2011 will be listed as "Winnipeg."

- The 2010 Free Agents list and 2010 Free Agent Signings list are current as of 11:34 PM May 20, 2011.

Search This Blog

Monday, June 28, 2010

Cheechoo, Kotalik Among NHL Players Currently on Waivers

On Monday, the following NHL players have been placed on waivers with the purpose of buying out their contracts. The players will have until noon tomorrow to be claimed by other teams. If they go unclaimed, they will likely have their contracts bought out and become unrestricted free agents.

Jonathan Cheechoo, RW - Ottawa
Ville Koistinen, D - Florida
Ales Kotalik, RW - Calgary
Petteri Nokelainen, C - Phoenix
Jim Vandermeer, D - Phoenix

I will be surprised if any of these players are claimed off waivers, as any team interested in acquiring them would be better off waiting until they are bought out and signing them to new, more affordable contracts. Cheechoo currently carries a $3.5 million price tag, and with only five goals and 14 points in 61 games last season, will likely keep any team from wanting to claim him. Kotalik, who is currently set to earn $3 million during each of the next two seasons, was wildly inconsistent last season with the New York Rangers and Calgary Flames, managing only 11 goals and 27 points in 71 games. His inconsistent play, lack of scoring, and salary will likely keep him from going claimed.

No comments: